Aemetis Reducing Interest Cost by ~80% using EB-5 Funding

$50 million EB-5 Phase II funding launched by CEO touring six countries in Asia and the Middle East
EB-5 Financing is Repaying 14% High Cost Bridge Loan with 3% Low Cost, Long Term Funding

CUPERTINO, CA – October 10, 2016 – Aemetis, Inc. (NASDAQ: AMTX), an advanced fuels and renewable chemicals company, announced that the $36 million EB-5 Phase I funding has been followed by the launch of a $50 million EB-5 Phase II funding to repay the existing 14% interest rate bridge loan with 3% interest rate, long term EB-5 funding.

Under the EB-5 Phase I funding, Aemetis offered subordinated notes in the amount of $500,000 per note to refinance the high interest rate bridge loan for the existing Keyes ethanol plant, and raised $36 million from 72 foreign investors. To date, $25 million of this amount has been released from the escrow account to the company and used to reduce a higher cost bridge loan held by our senior lender.

With an EB-5 project track record established, Aemetis recently commenced a $50 million Phase II funding with two Asian marketing tours by Aemetis Chairman and CEO Eric McAfee in July and August. Mr. McAfee officially launched the EB-5 Phase II funding in September 2016 with a tour of six countries including China, Vietnam, Taiwan, Singapore, Dubai and Abu Dhabi.

“We expect the proceeds from the $50 million EB-5 Phase II funding should be received into escrow during 2016,” Mr. McAfee stated. “Under the terms of the EB-5 Phase II offering, funding will be released from the escrow account to Aemetis within about a month after the investor deposits the funds, a significant decrease from up to the 18 months of escrow required by the earlier $36 million EB-5 Phase I program.”

Aemetis’ financing plan is to repay its high cost senior bridge loan with low cost EB-5 funding and funds from operations. This repayment of the senior bridge loan is expected to result in significant interest rate savings. Aemetis estimates that with about 20 million Aemetis shares outstanding, an interest rate reduction from 14% to 3% and the elimination of loan fees for the $68.5 million senior bridge loan would result in an annual interest and fee savings of more than $12 million per year (an increase of about $0.60 of earnings per share).

About Aemetis, Inc

Headquartered in Cupertino, California, Aemetis is an advanced fuels and renewable chemicals company founded in 2006. Aemetis owns and operates a 60 million gallon per year ethanol and 420,000 ton animal feed plant in California. Aemetis also owns and operates a 50 million gallon capacity renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds granted patents on technology for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.

Safe Harbor Statement
This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, statements regarding our business plans, growth opportunities, our ability to meet our funding goals under the EB-5 Phase II funding, our expectations regarding the timing of the receipt of funds from escrow and our expected cost savings from repayment of our senior bridge loan. Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “targets,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, completion of the terms of the agreement, completion of the EB-5 financing transactions, financial market risks, counter-party risks, risks associated with changes to government policy or regulation, and other risks detailed in our reports filed or to be filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2015 and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.

Aemetis CEO Eric McAfee Named to Biofuels Digest’s Top 100 People in the Advanced Bioeconomy 2016

Aemetis CEO Eric McAfee has been named #40 on Biofuels Digest’s list of the top 100 people in the advanced bioeconomy for 2016. Mr. McAfee is an entrepreneur and venture capitalist with a lifelong commitment to agriculture and renewable energy, and has been a founding shareholder in several publicly-held energy companies. At Aemetis, Mr. McAfee has created a company that, with the largest biofuel plant in California and a biodiesel plant serving the rapidly growing Indian market, fully represents his passion for renewable energy and biotechnology.

www.biofuelsdigest.com/bdigest/2016/01/31/the-top-100-people-in-the-advanced-bioeconomy-2016/7/

 

Aemetis CEO to Present at the Source Capital 2016 Disruptive Growth Conference

CUPERTINO, CA – February 8, 2016 – Aemetis, Inc. (NASDAQ: AMTX) today announced that Eric McAfee, Chairman and CEO, is scheduled to present at 10:45 am EST on Thursday, February 11, 2016 at the Source Capital 2016 Disruptive Growth and Healthcare Conference. The conference will be held at the Convene, 730 Third Avenue, New York City.

The Company’s corporate presentation is available on the Company’s website at www.aemetis.com.


About Aemetis

Headquartered in Cupertino, California, Aemetis is an advanced fuels and renewable chemicals company founded in 2006. Aemetis owns and operates a 60 million gallon per year ethanol and 420,000 ton animal feed plant in California. Aemetis also owns and operates a 50 million gallon capacity renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds nine granted patents on its Z-microbe and related technology for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.

Aemetis CEO to Present at Jefferies Industrials Conference

CUPERTINO, CA – August 7, 2015 – Aemetis, Inc. (NASDAQ: AMTX) today announced that Eric McAfee, Chairman and CEO is scheduled to present at 8:40 am EST on Monday, August 10th, 2015 at the Jefferies 2015 Industrials Conference, which is held at the Grand Hyatt Hotel in New York, NY.

 

The Company’s corporate presentation is available on the Company’s website at www.aemetis.com.

 

 

 

About Aemetis

Headquartered in Cupertino, California, Aemetis is an advanced fuels and renewable chemicals company founded in 2006. Aemetis owns and operates a 60 million gallon per year ethanol and 420,000 ton animal feed plant in California. Aemetis also owns and operates a 50 million gallon capacity renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds five granted patents on its Z-microbe and related technology for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.

Aemetis, Inc. Reports Second Quarter 2015 Financial Results

 

Aemetis, Inc. Reports Second Quarter 2015 Financial Results

 

CUPERTINO, Calif. – August 6, 2015 – Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and renewable chemicals company, today announced its financial results for the three and six months ended June 30, 2015.

 

“Our US ethanol business delivered sequential improvement in profitability and revenue,” stated Eric McAfee, Chairman and CEO of Aemetis.  “Our India biodiesel business grew 161% sequentially through the development of a sustainable domestic customer base, which was made possible by key government policy changes earlier in the year.  Continuation of this rapid customer acceptance and adoption places us on a strong path to year over year revenue growth.”

 

“Importantly, we received an additional $2.5 million of EB-5 subordinated debt funding during the second quarter. As of July 30, 2015, escrow account holds $11.5 million of EB-5 funding and an additional $3.0 million to be received into escrow later this year. This 3% interest rate funding will redeem higher rate senior debt,” said McAfee.

 

Financial Results for the Three Months Ended June 30, 2015

 

Revenues were $38.1 million for the second quarter of 2015, compared to $57.2 million for the second quarter of 2014. Decrease in ethanol and wet distiller’s grain average selling price resulted in revenue decline during the second quarter.  Gross profit for the second quarter of 2015 was $2.0 million, compared to $11.4 million in the second quarter of 2014.  During this period, ethanol and wet distiller’s grain pricing fell more rapidly than feedstock purchase cost.

 

Selling, general and administrative expenses were $3.1 million in the second quarter of 2015, compared to $3.4 million in the second quarter of 2014.  The decrease in selling, general and administrative expenses was driven by improved efficiencies and lower spending compared to the same period of the prior year.

 

Operating loss was $1.3 million for the second quarter of 2015 compared to operating income of $7.8 million for the same period in 2014.

 

Net loss of $6.3 million for the second quarter of 2015 compared to net income of $2.7 million for the second quarter of 2014.

 

Adjusted EBITDA for the second quarter of 2015 was a loss of $0.2 million, compared to Adjusted EBITDA of $9.1 million for the same period in 2014.

 

Cash at the end of the second quarter of $3.3 million compared favorably to $0.3 million at the close of 2014.

 

During the second quarter of 2015, the EB-5 program provided $2.5 million of low-cost debt funding.  Interest costs during the second quarter of 2015 were $4.9 million, slightly lower than the interest costs during the second quarter of 2014.

 

 

Financial Results for the Six Months Ended June 30, 2015

 

Revenues were $72.8 million for the first half of 2015, compared to $117.9 million for the first half of 2014.  Decrease in ethanol and wet distiller’s grain average selling price resulted in revenue decline for the first 6 months.  Gross profit for the first half of 2015 was $1.7 million, compared to $27.0 million during the first half of 2014.  During this period, ethanol and wet distiller’s grain pricing fell more rapidly than feedstock purchase cost.

 

Selling, general and administrative expenses were $6.8 million during the first half of 2015, compared to $6.3 million during the first half of 2014.  The increase in selling, general and administrative expenses was primarily attributable to a one-time EB-5 charge taken during the first quarter of 2015.

 

Operating loss was $5.3 million for the first half of 2015, compared to operating income of $20.4 million for the same period in 2014.

 

Net loss of $14.9 million for the first half of 2015 compared to net income of $10.4 million during the first half of 2014.

 

Adjusted EBITDA for the first half of 2015 was $2.5 million, compared to Adjusted EBITDA of $23.2 million for the same period in 2014.

 

During the first half of 2015, the EB-5 program provided $20.0 million of low-cost EB-5 debt funding.  Interest costs during the first half of 2015 were $9.5 million, compared to $10.2 during the first half of 2014 due to the lower cost of EB-5 funds in the capitalization structure.

 

 

About Aemetis

 

Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and renewable chemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of second-generation ethanol and biodiesel plants into advanced biorefineries.  Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in the California Central Valley near Modesto.  Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe.  Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals.  For additional information about Aemetis, please visit www.aemetis.com.

 

NON-GAAP FINANCIAL INFORMATION

 

We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest and amortization (income)/expense, depreciation expense, income/(expense) from share-based compensation and (gains)/losses resulting from debt extinguishment.

 

Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results and for budgeting and planning purposes.  EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison.

 

Safe Harbor Statement

 

This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, expectations for year over year revenue growth driven by increasing sales in India, expectations for uses of EB-5 funding and expectations for receipt of additional EB-5 funding.  Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “targets,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties.  Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2014, our Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.

 

 

 

(Tables follow)

 

 

 

AEMETIS, INC.

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

(unaudited, in thousands)

 

 

For the three months ended June 30

For the six months ended June 30

(in thousands, except per share)

2015

2014

2015

2014

Revenues

 $    38,067

 $        57,195

 $      72,793

 $    117,860

Cost of goods sold

       36,118

           45,842

         71,072

         90,883

Gross profit

         1,949

           11,353

           1,721

         26,977

Research and development expenses

            104

                141

              213

              241

Selling, general and administrative expenses

         3,149

             3,449

           6,782

           6,291

Operating income/(loss)

       (1,303)

             7,763

          (5,274)

         20,445

Interest rate expense

       (2,485)

            (2,530)

          (5,031)

          (5,450)

Amortization expense

       (2,405)

            (2,502)

          (4,128)

          (4,620)

Loss on debt extinguishment

              –

                   –

             (330)

             (115)

Gain (loss) on sale or disposal  of assets

              –

               (119)

                 –

             (119)

Other income/(expense)

            (94)

                110

              (161)

              274

Income/(loss) before income taxes

       (6,287)

             2,722

         (14,924)

         10,415

Income tax expense

              –

                   –

                 (6)

                 (6)

Net income/(loss)

 $    (6,287)

 $          2,722

 $       (14,930)

 $      10,409

Net Income/(loss) per common share*
Basic

 $      (0.32)

 $            0.13

 $         (0.74)

 $          0.52

Diluted

 $      (0.32)

 $            0.13

 $         (0.74)

 $          0.49

Weighted average shares outstanding*
Basic

       19,590

           20,284

         20,090

         20,146

Diluted

       19,590

           20,948

         20,090

         21,299

* The Earnings per share and Weighted average shares outstanding for all periods presented reflect the one-for-ten reverse split, which took effect May 15, 2014.

                                                                       


 

AEMETIS, INC.

CONSOLIDATED CONDENSED BALANCE SHEETS

(unaudited, in thousands)

June 30, 2015

December 31, 2014

Assets
Current assets:
Cash and cash equivalents

$3,325

$332

Accounts receivable

          2,143

                  1,262

Inventories

          5,427

                  4,491

Prepaid expenses and Other current assets

          1,364

                  1,848

Total current assets

        12,259

                  7,933

Property, plant and equipment, Net

        73,376

                75,810

Goodwill, Intangibles and Other assets

          5,516

                  5,433

Total assets

$91,151

$89,176

Liabilities and stockholders’ equity/(deficit)
Current liabilities:
Accounts payable

          8,208

                  8,339

Current portion of long term debt, notes and working capital

          6,399

                  6,032

Short term borrowings

          8,382

                  6,714

Mandatorily redeemable Series B convertible preferred stock

          2,690

                  2,641

Other current liabilities

          4,294

                  3,590

Total current liabilities

        29,973

                27,316

Long term liabilities
Senior secured notes

        57,375

                57,648

EB-5 notes

        21,685

                  1,534

Other long term

          5,800

                  5,650

Stockholders’ deficit

       (23,682)

                 (2,972)

Total liabilities and stockholders’ equity/(deficit)

$91,151

$89,176

 

 

RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS)

(unaudited, in thousands)

 

For the three months ended   June 30

For the six months ended June 30

2015

 

2014

2015

 

2014

Net income/(loss)  $    (6,287)  $      2,722  $  (14,930)  $    10,409
Adjustments:
Interest rate expense          2,485          2,530          5,031          5,450
Amortization expense          2,405          2,502          4,128          4,620
Loss on debt extinguishment               –               –             330             115
Income tax expense               –               –                 6                 6
Intangibles and other amortization expense               32               32               64               64
Depreciation expense          1,193          1,150          2,388          2,302
Share-based compensation             380             159             533             290
Total adjustments          6,495          6,373        12,480        12,847
Adjusted EBITDA  $         208  $      9,095  $    (2,450)  $    23,256

PRODUCTION AND PRICE PERFORMANCE

(unaudited)

For the three months ended June 30,

For the six months ended June 30,

2015

 

2014

2015

 

2014

Ethanol
Gallons sold (in millions)                14.2            14.9            28.4            31.0
Average sales price/gallon  $            1.78  $        2.74  $        1.73  $        2.83
WDG
Tons sold (in thousands)                93.5          101.9          187.2          214.4
Average sales price/ton  $               82  $         115  $           86  $         106
Biodiesel
Metric tons sold (in thousands)                  3.6              3.1              4.4              4.1
Average sales price/metric ton  $             802  $         921  $         836  $         933
Refined Glycerin
Metric tons sold (in thousands)                  1.6              0.4              2.7              1.0
Average sales price/metric ton  $             661  $         964  $         668  $      1,004

Aemetis to Review Q2:15 Financial Results on August 6, 2015

CUPERTINO, CA – August 3, 2015 – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host an earnings review call regarding the release of its second quarter 2015 earnings report:

 

Date:   Thursday, August 6, 2015

 

Time:   9:00 am Pacific Time (PT)

 

Live Participant Dial In (Toll Free): +1 (877) 407-8133

 

Live Participant Dial In (International): +1 (201) 689-8040

 

Webcast URL: http://www.investorcalendar.com/IC/CEPage.asp?ID=174256

 

Attendees may submit questions during the Q&A portion of the conference call.

 

After August 6th, the webcast will be available on the Company’s website (www.aemetis.com) under Investors/Conference Calls.  The voice recording will also be available through August 14th, 2015 by dialing +1 (877) 660-6853 (Toll Free) or +1 (201) 612-7415 (International) and entering conference ID number 13616722.

 

About Aemetis

Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries.  Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in the California Central Valley near Modesto.  Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe.  Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals.  For additional information about Aemetis, please visit www.aemetis.com.